American Association for Cancer Research - AACR Congress, 2016

作者：Vicier C^*; De Guillebon E^*; Kieffer A^*; Turpin A^*; Dumont C^*; Bellesoeur A^*; Soares D G^*; Lotz J P^*

来源：Oncologie, 2016, 18(7-8): 433-449.

DOI：10.1007/s10269-016-2647-z

• AACR
• Cancer
• Personalized medicine
• Heterogeneity
• Immunotherapy
• Targeted therapy
• Genomics
• Stem cells
• Metabolism

This year, the theme of the American Association for Cancer Research (AACR) conference that held from the 16th to the 20th of April 2016 was "Delivering Cures through Cancer Science". Its objective was to reinforce the link existing between research and advances in patient's care. As usual, the multidisciplinary program covered all the areas of cancer science. Beyond the plenary sessions and symposiums, the program of the meeting included didactic educational workshops on specific areas of research offering a good opportunity to learn or to extend knowledge on particular issues. The meeting also permitted active discussion and exchanges with colleagues through the poster sessions. In this issue of Oncologie, and for the third year in a row, mentoring medical doctors of the French association, AERIO (Association d'enseignement et de recherche des internes d'oncologie) focus on presentations that, to our opinion, warranted a particular attention. The aim of this exciting and informative project is not only to provide details to researchers and physicians but also to the general public who could not attend the conference. This year, genetic and epigenetic cancer heterogeneity as well as tumor immunology received a particular and still increasing attention by the AACR steering committee. However, we also report here the most recent advances on tumor metabolism and its signaling pathways, a rapidly growing research field that should allow, in the near future, to identify potential drug targets and to develop compounds capable of starving and inhibiting tumor progression.

• 出版日期2016-7